NIH-funded research NIH-funded research

BabyStrong II: gentle ear stimulation during bottle feeds to help babies learn to eat by mouth

Official title: BabyStrong II (Stimulating the Tragus for Neural Growth): A Randomized Controlled Trial of taVNS-Paired Bottle Feeding to Improve Oral Feeding

Funded at Frd Accel, LLC · NIH-11178706 · Data updated 2026-11-12

This tests whether gentle ear (tragus) vagus-nerve stimulation given during bottle feeds helps preterm and brain-injured infants reach full oral feeding sooner.

More Randomized Controlled Trial research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionFrd Accel, LLC
NIH-funded
Lab location1 site (Charleston, United States)
Project startJune 7, 2021
Project endAugust 31, 2026
Funding year2025
Award (this year)$969,472
NIH project number5R42HD104409-03
Project IDNIH-11178706 on NIH RePORTER

Who could benefit from this research

Could help

Preterm or term infants with brain injury who are hospitalized for feeding delays and are not yet reliably taking full oral feeds.

Less likely to help

Infants who are already feeding well, are medically unstable, or have contraindications to vagus nerve stimulation may not benefit or be eligible.

What this research studies

This project pairs a non-invasive ear (tragus) vagus nerve stimulation device with regular bottle feeding in the neonatal unit. Babies are randomly assigned to receive the stimulation during feeds or to continue usual feeding care while teams track feeding progress and time to full oral feeds. The approach is non-invasive and was piloted in infants, where over half of babies discussed for G-tube placement reached full feeds within two weeks. The team aims to turn this method into a therapy that helps infants go home sooner and avoid gastrostomy tubes.

Why it matters

Potential benefit: If successful, this could help more infants reach full oral feeding faster and reduce the need for G-tube placement.

How similar studies have gone: Early open-label pilot work in infants showed promising results—54% of babies discussed for G-tube placement reached full feeds within two weeks—so randomized testing is now under way.

Where this research is happening

  • Frd Accel, LLC
    Charleston, United States
    Active

Researchers

  • Principal investigator: Jenkins, Dorothea Denise — Frd Accel, LLC
  • Study coordinator: Jenkins, Dorothea Denise

Related research

Other NIH-funded projects on the same topics.

  • Cognitive behavioral therapy and trazodone for insomnia phenotypes with high blood pressure

    A clinical study tests how CBT-I and the sleep drug trazodone work for adults with insomnia and high blood pressure, focusing on a specific sleep duration pattern.

    NIH research Pennsylvania State Univ Hershey Med Ctr · Hershey, United States · NIH-11635771

  • Shorter antifungal treatment for kids with candidemia

    A multi-center pediatric trial tests whether a shorter, 7 extra days of antifungal therapy after an initial 7 days is just as good as the standard 14-day approach for kids with candidemia who are improving on echinocandin therapy.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606539

  • Short Course vs Standard Course Antifungal Therapy for Pediatric Candidemia

    This study tests whether a shorter 7-day total antifungal treatment after an initial 7 days of echinocandin therapy is as effective as the usual 14-day course for children with candidemia.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606535

  • Shorter antifungal treatment for kids with candidemia

    A multi-center study tests whether kids with candidemia can finish treatment earlier after an initial week of antifungal therapy than the standard two weeks total.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606531

  • Shorter antifungal treatment for kids with candidemia

    This study tests whether children with candidemia can finish treatment after 7 days of an echinocandin if they are improving, instead of completing a full 14 days.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606505

  • Shorter antifungal course for kids with candidemia

    A multi-center study tests whether 7 extra days of antifungal therapy after an initial week of treatment can be shortened safely for children with candidemia.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606502

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.